New York Assembly Bill 6927: Relates to prescription labels for gonadotropin-releasing hormone agonists, pubertal suppressants, anabolic steroids, alpha reductase inhibitors, progestins, or drug classes for hormone replacement therapy

New York · 2025-2026 session

Status: Introduced

What it does

Provides that prescription labels for gonadotropin-releasing hormone agonists, pubertal suppressants, anabolic steroids, alpha reductase inhibitors, progestins, or drug classes for hormone replacement therapy maybe include the name of the dispensing practice instead of the prescriber; provides for notice to patients.

Latest action

PRINT NUMBER 6927A (2026-05-28)

See how A 6927 affects you on CapitolKey

Browse more bills · CapitolKey home